![]() |
市场调查报告书
商品编码
1629618
腹膜透析市场按产品类型、应用、最终用户和地区划分Peritoneal Dialysis Market, By Product Types, By Applications (Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis ), By End User, By Geography |
2024 年全球腹膜透析市场规模估计为 94.2 亿美元,预计 2031 年将达到 139 亿美元,2024 年至 2031 年的复合年增长率为 5.7%。
报告范围 | 报告详细信息 | ||
---|---|---|---|
基准年 | 2023 | 2024 年的市场规模 | 94.2亿美元 |
效能资料 | 2019-2023 | 预测期 | 2024 至 2031 年 |
预测期间 2024 年至 2031 年复合年增长率: | 5.70% | 2031 年价值预测 | 139亿美元 |
全球腹膜透析市场的成长是由慢性肾臟病盛行率的上升和家庭血液透析机治疗需求的不断增长所推动的。腹膜透析是一种透过腹部的腹膜交换液体和电解质的肾臟替代疗法。腹膜透析比传统血液透析机有许多优势,包括饮食限制更少、生活品质更高、液体管理更好。此外,开发中国家人口老化加剧、更容易患慢性病以及医疗成本上升可能会推动对腹膜透析的需求。然而,一些国家缺乏经验丰富的肾臟病专家和报销问题等因素可能会阻碍市场成长。
推动全球腹膜透析市场成长的关键因素包括导致末期肾病的糖尿病和高血压盛行率不断上升、已开发国家对家庭透析治疗治疗的优惠报销政策、以及作为医院血液透析机替代方案的慢性肾臟病治疗的需求不断增长。腹膜透析因其优于血液透析机而变得越来越受欢迎,包括改善生活品质、灵活性和减少饮食限制。然而,训练有素的肾臟科专家短缺,特别是在开发中国家和欠发达地区,长期腹膜透析引起的腹膜炎风险也带来了挑战。此外,偏远地区缺乏透析基础设施也阻碍了市场的成长。腹膜透析设备、导管和提高透析效果和患者舒适度的解决方案的技术创新不断增加,为市场扩张提供了机会。
本研究的主要特点
本报告对全球腹膜透析市场进行了详细分析,并展示了预测期(2024-2031 年)的市场规模(十亿美元)和年复合成长率(CAGR%),以 2023 年为基准年。
它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球腹膜透析市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行的分析。
研究中介绍的主要企业包括百特国际公司 (Baxter International Inc.)、费森尤斯医疗保健股份公司 (Fresenius Medical Care AG & Co. KGaA)、美敦力公司 (Medtronic plc)、B. Braun Melsungen AG. Dialife SA、Renal Solutions, Inc.、东丽株式会社 (Toray Industries, Inc.)、日本光电株式会社 (Nihon Kohden Corporation)、百特医疗集团 (Baxter Healthcare Corporation)、SWS 血液透析护理公司 (SWS Hemodialysis Care, Inc.) 和安斯泰来製药公司 (Astellas Pharma Inc.)。
从本报告中获得的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球腹膜透析市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球腹膜透析市场的各种策略矩阵来促进决策。
Global peritoneal dialysis market is estimated to be valued at USD 9.42 Bn in 2024 and is expected to reach USD 13.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 9.42 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 5.70% | 2031 Value Projection: | US$ 13.90 Bn |
Global peritoneal dialysis market growth is driven by rising prevalence of chronic kidney disease and growing demand for home hemodialysis treatment. Peritoneal dialysis is a kidney replacement therapy performed using fluid and electrolyte exchange through the peritoneal membrane in the abdomen. It offers various advantages over conventional hemodialysis such as fewer dietary restrictions, improved quality of life, and better fluid management. Moreover, growing geriatric population prone to chronic diseases and increasing healthcare expenditure in developing nations can boost demand for peritoneal dialysis procedures. However, factors such as lack of experienced nephrologists and reimbursement issues in some countries may hamper the market growth.
Key drivers propelling the global peritoneal dialysis market growth include growing prevalence of diabetes and hypertension leading to end-stage renal disease, favorable reimbursement policies for home dialysis therapies in developed nations, and increasing demand for chronic kidney disease treatment alternatives to hospital-based hemodialysis. Benefits of peritoneal dialysis over hemodialysis such as improved quality of life, flexibility, and less dietary restrictions boosts its adoption rates. However, shortage of trained nephrologists especially in developing and underdeveloped regions and risk of peritonitis with long-term peritoneal dialysis pose challenges. Moreover, lack of dialysis infrastructure in remote areas can also hamper the market growth. Ongoing innovations in peritoneal dialysis machines, catheters and solutions aimed at enhancing efficacy and patient comfort offer opportunities for market expansion.
Key Features of the Study
This report provides in-depth analysis of the global peritoneal dialysis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peritoneal dialysis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, B. Braun Melsungen AG, Nipro Corporation, Cook Medical, Asahi Kasei Medical Co., Ltd., Gambro (part of Fresenius), Dialife SA, Renal Solutions, Inc., Toray Industries, Inc., Nihon Kohden Corporation, Baxter Healthcare Corporation, SWS Hemodialysis Care, Inc., and Astellas Pharma Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global peritoneal dialysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peritoneal dialysis market